Gianmaria Cammarota to Clostridium Infections
This is a "connection" page, showing publications Gianmaria Cammarota has written about Clostridium Infections.
Connection Strength
5.067
-
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study. Dig Liver Dis. 2020 12; 52(12):1390-1395.
Score: 0.497
-
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic. Gut. 2020 09; 69(9):1555-1563.
Score: 0.489
-
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice. Gut. 2019 12; 68(12):2111-2121.
Score: 0.464
-
Emerging drugs for the treatment of clostridium difficile. Expert Opin Emerg Drugs. 2019 03; 24(1):17-28.
Score: 0.447
-
Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: A pre-post analysis in a Third Level Referral Center. Int J Infect Dis. 2019 Mar; 80:105-110.
Score: 0.442
-
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions. Aliment Pharmacol Ther. 2018 07; 48(2):152-159.
Score: 0.423
-
Faecal Microbiota Transplantation as Emerging Treatment in European Countries. Adv Exp Med Biol. 2018; 1050:177-195.
Score: 0.411
-
Fecal microbiota transplantation: past, present and future perspectives. Minerva Gastroenterol Dietol. 2017 Dec; 63(4):420-430.
Score: 0.409
-
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year cohort study: authors' reply. Clin Microbiol Infect. 2017 11; 23(11):891.
Score: 0.393
-
Faecal microbiota transplantation in clinical practice. Gut. 2018 01; 67(1):196-197.
Score: 0.391
-
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study. Clin Microbiol Infect. 2017 May; 23(5):337.e1-337.e3.
Score: 0.384
-
Clostridium difficile: trend in an Italian Tertiary Care Hospital during fifteen years, 2002-2016. Minerva Med. 2019 Apr; 110(2):168-171.
Score: 0.112
-
Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update. Drugs Today (Barc). 2018 Feb; 54(2):123-136.
Score: 0.103
-
Fecal calprotectin in management of Clostridium difficile infection: a longitudinal study. Scand J Gastroenterol. 2018 05; 53(5):567-572.
Score: 0.101